Skip to Content

Daliresp Side Effects

Generic Name: roflumilast

Note: This document contains side effect information about roflumilast. Some of the dosage forms listed on this page may not apply to the brand name Daliresp.

In Summary

More frequent side effects include: diarrhea, headache, nausea, weight loss, and psychiatric signs and symptoms. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to roflumilast: oral tablet

Along with its needed effects, roflumilast (the active ingredient contained in Daliresp) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking roflumilast:

More Common

Less Common

  • Chills
  • cough
  • diarrhea
  • discouragement
  • fear or nervousness
  • feeling sad or empty
  • fever
  • general feeling of discomfort or illness
  • headache
  • irritability
  • joint pain
  • loss of appetite
  • loss of interest or pleasure
  • muscle aches and pains
  • nausea
  • runny nose
  • shivering
  • sleeplessness
  • sore throat
  • sweating
  • thoughts of killing oneself or changes in behavior
  • tiredness
  • trouble concentrating
  • trouble sleeping
  • unable to sleep
  • unusual tiredness or weakness
  • vomiting

Some side effects of roflumilast may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less Common

  • Abdominal or stomach pain
  • back pain
  • bladder pain
  • bloody or cloudy urine
  • burning feeling in the chest or stomach
  • decreased appetite
  • difficult, burning, or painful urination
  • dizziness
  • frequent urge to urinate
  • indigestion
  • lower back or side pain
  • muscle spasm
  • pain or tenderness around the eyes and cheekbones
  • shakiness in the legs, arms, hands, or feet
  • shortness of breath or troubled breathing
  • sneezing
  • stomach upset
  • stuffy or runny nose
  • sweating
  • tenderness in the stomach area
  • tightness of the chest or wheezing
  • trembling or shaking of the hands or feet

For Healthcare Professionals

Applies to roflumilast: oral tablet


During clinical trials, treatment was discontinued due to side effects in 14.8% of patients treated with roflumilast (the active ingredient contained in Daliresp) and 9.9% of patients treated with placebo. The most common side effects leading to roflumilast discontinuation were diarrhea and nausea. Serious side effects, whether considered drug-related or not by investigators, which occurred more often in patients treated with roflumilast included diarrhea, atrial fibrillation, lung cancer, prostate cancer, acute pancreatitis, and acute renal failure.[Ref]


Psychiatric side effects have included increased psychiatric adverse reactions (5.9%) including insomnia (2.4%), anxiety (1.4%), and depression (1.2%). Instances of suicidal ideation and behavior (including suicide attempt and completed suicide) have been reported.[Ref]


Gastrointestinal side effects have included diarrhea (9.5%), nausea (4.7%), and acute pancreatitis. Abdominal pain, dyspepsia, gastritis, and vomiting have been reported in 1% to 2% of patients.[Ref]


In 2 clinical trials, moderate weight loss (5% to 10% of body weight) was reported in 20% of patients receiving roflumilast (the active ingredient contained in Daliresp) compared to 7% of patients who received placebo. Severe weight loss (greater than 10% body weight) was reported in 7% of patients who received roflumilast compared to 2% of patients receiving placebo.

Metabolic side effects have included weight loss (7.5%).

Nervous system

Nervous system side effects have included headache (4.4%), dizziness (2.1%), and tremor (1% to 2%).[Ref]


Other side effects have included decreased appetite (2.1%).


Musculoskeletal side effects have included back pain (3.2%) and muscle spasms (1% to 2%).[Ref]


Respiratory side effects have included influenza (2.8%), rhinitis (1% to 2%), and sinusitis (1% to 2%).[Ref]


Genitourinary side effects have included urinary tract infection (1% to 2%).[Ref]


Cardiovascular side effects have included atrial fibrillation.[Ref]


Oncologic side effects have included lung cancer and prostate cancer.


Renal side effects have included acute renal failure.[Ref]


Hypersensitivity side effects postmarketing have included angioedema, urticaria and rash.


1. "Product Information. Daliresp (roflumilast)." Forest Pharmaceuticals, St. Louis, MO.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.